NM_004139.5:c.276G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_004139.5(LBP):c.276G>A(p.Ala92Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,613,664 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 3 hom. )
Consequence
LBP
NM_004139.5 synonymous
NM_004139.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.44
Publications
2 publications found
Genes affected
LBP (HGNC:6517): (lipopolysaccharide binding protein) The protein encoded by this gene is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI), the encoded protein binds LPS and interacts with the CD14 receptor, probably playing a role in regulating LPS-dependent monocyte responses. Studies in mice suggest that the encoded protein is necessary for the rapid acute-phase response to LPS but not for the clearance of LPS from circulation. This protein is part of a family of structurally and functionally related proteins, including BPI, plasma cholesteryl ester transfer protein (CETP), and phospholipid transfer protein (PLTP). [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 20-38350847-G-A is Benign according to our data. Variant chr20-38350847-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 735262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.44 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00102 AC: 156AN: 152204Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
156
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00107 AC: 268AN: 251022 AF XY: 0.00114 show subpopulations
GnomAD2 exomes
AF:
AC:
268
AN:
251022
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00142 AC: 2081AN: 1461342Hom.: 3 Cov.: 30 AF XY: 0.00137 AC XY: 998AN XY: 726920 show subpopulations
GnomAD4 exome
AF:
AC:
2081
AN:
1461342
Hom.:
Cov.:
30
AF XY:
AC XY:
998
AN XY:
726920
show subpopulations
African (AFR)
AF:
AC:
14
AN:
33462
American (AMR)
AF:
AC:
17
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
13
AN:
26130
East Asian (EAS)
AF:
AC:
3
AN:
39690
South Asian (SAS)
AF:
AC:
45
AN:
86242
European-Finnish (FIN)
AF:
AC:
16
AN:
53246
Middle Eastern (MID)
AF:
AC:
13
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
1876
AN:
1111704
Other (OTH)
AF:
AC:
84
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
107
214
321
428
535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00102 AC: 156AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.00103 AC XY: 77AN XY: 74492 show subpopulations
GnomAD4 genome
AF:
AC:
156
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
77
AN XY:
74492
show subpopulations
African (AFR)
AF:
AC:
12
AN:
41580
American (AMR)
AF:
AC:
9
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5178
South Asian (SAS)
AF:
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
AC:
3
AN:
10612
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
126
AN:
68026
Other (OTH)
AF:
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 31, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.